Key Takeaways & Executive Findings
- •• Circadian rhythms modulate immune cell behavior and cytokine production, influencing the tumor microenvironment and immunotherapy efficacy. • Chrono-immunology reveals that timing of adoptive cellular therapy and immune checkpoint blockade can improve treatment outcomes. • Disruption of circadian rhythms promotes tumor progression by dysregulating metabolism, DNA repair, and immune function. • Integrating circadian rhythm concepts into clinical protocols may optimize cancer immunotherapy and cellular therapy responses.
Abstract
Immunotherapy, including cellular therapy, has emerged as a crucial pillar in cancer treatment, complementing established modalities such as surgery, chemotherapy and radiotherapy. The clinical observation that immunotherapy is effective in only a limited proportion of patients inspires mechanistic research on the complicated regulatory network within the tumor microenvironment (TME). Circadian regulation significantly affects immune cell behavior, including the activity of immune cells and cytokine production, and emerging evidence suggests the key role of circadian regulation in the TME, which subsequently affects the effectiveness of immunotherapy. Results from preclinical and clinical studies indicate that appropriate timing of adoptive cellular therapy and immune checkpoint blockade therapy improves their efficacy. Therefore, understanding the molecular mechanism of the circadian rhythm together with its role in immunotherapy is essential for optimizing cellular function, proliferation and persistence in the TME. Here, we review how circadian rhythms influence immunotherapy and the TME across different stages of tumor progression. Future clinical protocols may integrate concepts of circadian rhythm and immunotherapy to enhance treatment response.
1. Introduction
Circadian rhythms are innate cycles that last approximately 24 hours and regulate physiological and behavioral processes. These rhythms are orchestrated by an internal timekeeping system commonly referred to as the biological clock, which aligns bodily functions with the environmental light-dark cycle [1]. Mechanistically, circadian rhythms are regulated by interlocking feedback loops involving genes such as CLOCK, BMAL1, PER, and CRY and their protein products, which regulate gene expression and downstream physiological pathways [2]. These loops generate self-sustaining oscillations even under constant environmental conditions, although they can be synchronized by several external cues, particularly light, temperature, and feeding schedules [1]. The circadian rhythm in mammals consists of both central and peripheral rhythms. The central rhythm governed by the suprachiasmatic nucleus (SCN) of the hypothalamus synchronizes the body, whereas peripheral rhythms occur in most tissues and organs, regulating processes such as metabolism, hormone release, and cardiovascular function [3]. Coordinating these clocks ensures temporal order across biological systems, optimizing function and survival.
Circadian rhythms, driven by the transcriptional feedback loops of core clock genes, orchestrate a wide array of key physiological processes, such as cell cycle progression, DNA repair, hormone secretion, and especially immune homeostasis. This interplay, often referred to as chrono-immunology, has become a key area of study for understanding how fluctuations in physiological processes across the diurnal cycle influence immune function. Specifically, circadian rhythms modulate immune responses by affecting the expression of clock genes in macrophages, T cells and other immune cells, leading to differential levels of cytokine release, antigen presentation, and cell migration [4]. A comprehensive review revealed that both innate and adaptive immune responses exhibit rhythmic behavior [5]. For example, the circadian regulation of DC activity and T-cell proliferation results in time-of-day-dependent responses to infection and vaccination efficacy. More recent findings have explored the mitochondrial-level regulation of immune cells by the circadian clock, revealing how oxidative phosphorylation and energy production are also time sensitive and further linking the circadian rhythm to the metabolism of immune cells [6]. In addition, mitochondrial isocitrate dehydrogenase is associated with CAR-T-cell function through histone acetylation and metabolism [7]. Circadian rhythm disruptions alter cellular metabolism, DNA repair, and immune function, which can accelerate aging and cancer development [8]. The circadian rhythm intricately tunes the immune system through gene regulation, hormonal balance, and cellular metabolism. Potential therapeutic strategies, including chronotherapy and anti-aging interventions, are proposed to target these interconnected pathways for improved cancer management [8]. Recognizing this link has opened new avenues in chronotherapy, where treatments such as vaccines or immunomodulators may be optimized on the basis of time-of-day administration [9].
Loading authentic research manuscript (Pages 1–5)...
Xiaoyang Sun, Lulu Qin, Xinghua Liang, Dongrui Wang (2026). Circadian rhythm in immunotherapy and cellular therapy: impacts on the tumor microenvironment. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025203
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the role of circadian rhythm in immunotherapy?
Circadian rhythm modulates immune cell behavior, cytokine production, and the tumor microenvironment, thereby influencing the efficacy of immunotherapies such as immune checkpoint blockade and adoptive cellular therapy. Timing these treatments according to circadian rhythms may improve outcomes.
How does circadian disruption affect tumor progression?
Disruption of circadian rhythms, often due to shift work or sleep deprivation, can dysregulate metabolism, DNA repair, and immune function, thereby promoting tumor progression and potentially reducing the effectiveness of cancer treatments.
What is chrono-immunology?
Chrono-immunology is the study of how circadian rhythms influence immune function. It examines how the body's internal clock affects immune cell activity, cytokine release, and responses to infections and vaccinations, with implications for optimizing cancer immunotherapy.
Can timing of cancer therapy improve its efficacy?
Yes, preclinical and clinical studies suggest that administering adoptive cellular therapy or immune checkpoint inhibitors at specific times of day, aligned with circadian rhythms, can enhance their efficacy by optimizing immune cell function and the tumor microenvironment.
What are the future directions for integrating circadian rhythm into cancer treatment?
Future clinical protocols may incorporate circadian rhythm concepts to personalize treatment timing, potentially improving response rates and reducing side effects. This approach, known as chronotherapy, could be combined with existing immunotherapies to enhance overall treatment effectiveness.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.